StemCell Therapy

Eighteen-year-old Aisha Choudhary was just like any other adolescent eyes filled with dreams and a heart brimming with energy. The only difference was she was battling a rare genetic disease, Severe Combined Immune Deficiency (SCID). Diagnosed when she was six months old and undergoing medical treatment for years, she was iron-willed in playing the cards she was dealt.

Since one of the most effective cures for SCID is a stem cell transplant (grafting of the parent cells from which all blood cells develop), Aishas parents, Niren and Aditi, decided to opt for that treatment mode. But their cells were not a complete match with their daughters, and they had to look at external donors. However, due to a low number of voluntary, registered stem cell donors, Aisha could not get a compatible donor whose genetic markers were a close enough match to hers. With no other alternative treatment available, Aisha had a bone marrow transplant. But, it came with a side-effect that cost her life Pulmonary Fibrosis, a disease known to damage the lung tissues.

Aishas Choudhary's role has been played by Zaira Wasim in The Sky is Pink.

Aishas journey has been captured in The Sky is Pink, a recent Bollywood movie starring Priyanka Chopra, Farhan Akhtar, Zaira Wasim, and Rohit Saraf.

The 18-year-olds life story is mirrored in the experiences of many who await stem cell donation as treatment for blood-related illnesses likeleukemia, lymphoma, and sickle cell anemia every year. With very few individuals signing up as donors and the probability of finding a match being a dismal 0.0008 percent in India (against a lean 16 percent abroad), fatalities are mounting year on year.

However, in recent times, there has been one small break in the clouds a number of youngsters, non-governmental organisations, and medical professionals have come forward and are working to spread awareness about stem cell donation and motivate a larger number of people to register as donors.

The stem cells in a human body mainly comprise red blood cells, platelets, and white blood cells. These are found in the umbilical cord of newborns and in the peripheral or circulating blood and bone marrow.

A stem cell donation is as simple and painless as a blood donation.

Certain diseases like blood cancer and leukemia tend to destroy the bone marrow or affect its functioning.For these, treatments like chemotherapy and radiotherapy are tried initially. However, in some cases, they do not prove effective for a cure. The only recourse then is replacing the patients stem cells with those of a healthy person.

One of the main criteria for a successful transplant is a good match between the stem cells of the donor and those of the patient. Therefore, a donor registry will administer a cheek swab test (tissue samples extracted from the cheek) on all potential donors to match cell characteristics. This procedure of pairing generic markers is called Human Leukocyte Antigen (HLA) in medical terms.

A cheek swab test in progress.

Each potential donors tissue is entered in the registry and given an identification number after the test is done. If the registry finds a match at any point in time, the donor is contacted to initiate the transplant.

There are many organisations today that are leading the charge in saving the lives of people suffering from serious blood disorders like cancer, thalassemia, and anaemia.

For instance, Datri, an Ahmedabad-based NGO, is working to create a wide and diverse database of potential stem cell donors by organising donation drives. Founded in 2009 by two doctors and an engineer, the organisation focuses on conducting awareness campaigns and helping individuals sign up on its registry as a committed and voluntary benefactor.

The team of the NGO Datri.

The idea for Datri was initially born in the minds of doctors Nezih Cereb and Soo Young Yang, who run a laboratory, Histogenetics, for determining tissue matches between patients and donors. Since pairing tissue types is imperative for any stem cell transplant, and confronting a severe shortage of donors, the doctor duo would run from pillar to post to meet hospitals requirements. Working with a number of the hospitals in India, they realised just how acute the shortfall was in people willing to donate stem cells. They recognised the immediate need to create a donor registry here.

Soon after, Raghu Rajagopal, an engineer from BITS Pilani and Director of ready-to-eat venture Millets and More, connected with them and they decided to start Datri.

Today, the functioning of the registry, its maintenance, and even the substantial costs involved in conducting the HLA matching are taken care of by the lab. In the last 10 years, Datri has gotten over four lakh people to register as donors and has saved around 600 lives through successful transplantation.

Every day, about 40 people are diagnosed with blood disorders in India. Though these can be cured through a stem cell transplant from a genetically matched donor, there is only a 25 percent chance of finding a match from within the family. Others have no option but to rely on unrelated donors. But the chances of getting a match is anywhere between one in 10,000 and one in two million. There is an urgent need to rope in as many potential donors as possible, which is precisely what Datri is trying to do, Raghu explains.

Another organisation that is dedicated to fighting blood disorders with stem cell treatment is DKMS-BMST. It was formed through a joint venture between two renowned NGOs DKMS, which is one of the largest international blood stem cell donor centres globally, and the Bangalore Medical Services Trust (BMST).

The team of DKMS-BMST.

DKMS was founded in Germany in 1991 by businessman Dr Peter Harf, after he lost his wife to leukemia. BMST was born in 1984 from the vision of Dr Latha Jagannathan, a medical director and managing trustee. Since both organisations had a common goal to find a matching donor for every patient with a blood disorder, they decided to come together to achieve it.

A group of youngsters registering to be stem cell donors.

So far, more than 37,000 people in India have registered as potential donors after attending DKMS-BMSTs donor drives.

In highly populous countries like India, thousands of people are in need of stem cell transplants every year to survive. Though donating stem cells is a painless and non-invasive process, it remains a lesser-known medical concept in India, with only 3.6 lakh people willing to play a part in it. Besides, the chances of stem cells of people of the same ethnicity matching are higher than those of individuals from different ethnic backgrounds. But, it is due to sheer lack of awareness that India lags severely in stem cell donations, say experts.

Students taking a cheek swab test at one of the colleges in Bengaluru.

Dr Govind Eriat, a reputed hematologist and bone marrow transplant specialist, says,

With a major hurdle to stem cell donation in India proving to be the myths surrounding the subject, the youth are coming forward to deconstruct common misconceptions.

For instance, 21-year-old Tejaswini Patel, a student of Information Science at New Horizon College of Engineering, Bengaluru, has been busting the false ideas on stem cell donation, starting among her family and friends. She says,

She adds, with a notable sense of pride, In the last two years alone, around 400 students from my college have registered themselves as donors.

(Edited by Athirupa Geetha Manichandar)

Read more:
How Young India is fuelling the future of stem cell therapy and signing up to save lives - YourStory

By Express News Service

PURI:Stem cell therapy has offered hope to parents of children suffering from serious neurological disorders, said Dr Richa Bansod of Mumbai-based NeuroGen Brain and Spine Institute (BSI), here on Thursday.

She said latest advances in therapy hold great promise for autism in children. But they are suffering due to lack of awareness among parents.

Early treatment can significantly improve the condition and also effect recovery from the disorder, Dr Bansod said at a media conference here.

Citing one such example, she presented 16-year-old Anurag Champi of Bhubaneswar who has shown significant improvement after stem cell therapy. At present, the boy is being imparted speech therapy and necessary exercise to enable him for voice interface, said his mother Sangita.

In order to create awareness on the therapy among parents, a free autism treatment camp will be organised at Bhubaneswar on November 16. We are also providing free treatment to poor families at our Mumbai facility, said Dr Bansod.

Through neuro regenerative rehabilitation and stem cell therapy, brain stroke, brain and spine injuries caused by accident could be effectively treated, she added. Deputy Director of the institute Dr Nandini Gokulchandran was present.

Read the original post:
Stem cell therapy hope for autism patients - The New Indian Express

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Click to copy

IRVINE, Calif., Oct. 15, 2019 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that the Companys ROOT of SKIN line of rejuvenating skincare products sold out in its tenth appearance on the Japanese home shopping channel QVC Japan.

ROOT of SKIN is AIVITAs proprietary skincare line for skin rejuvenation, made possible through the same proprietary knowledge and expertise used to develop its cutting-edge stem cell therapies. SourceCode Technology, the proprietary actives complex in ROOT of SKIN, contains the complete set of factors and supporting biological components present in young, healthy skin.

AIVITA Biomedical uses 100% of the proceeds from ROOT of SKIN sales to support the treatment of women with ovarian cancer.

Outstanding market traction, a product that truly works, and a benevolent use of proceeds, said Hans Keirstead, AIVITAs Chief Executive Officer. This sets the stage for global expansion of our ROOT of SKIN product line.

About ROOT OF SKIN

ROOT of SKIN is a rejuvenating line of skincare products fueled by an unrelenting pursuit for advancements in life-changing and life-saving treatments. Harnessing breakthroughs in stem cell therapy, AIVITA Biomedical developed a technology that does more than just boost regeneration. The patented actives complex SourceCode Technology renews, repairs and protects, just as your skin did at its youngest and healthiest stage. Rich with every biological component healthy skin needs for development, and free of any unnecessary ingredients. All proceeds support treatment of women with ovarian cancer.

About AIVITA Biomedical

AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its therapeutic pipeline and commercial line of skin care products.

View original content to download multimedia: http://www.prnewswire.com/news-releases/root-of-skin-skincare-products-sell-out-in-tenth-consecutive-appearance-on-qvc-japan-300938926.html

SOURCE AIVITA Biomedical, Inc.

Continue reading here:
ROOT OF SKIN Skincare Products Sell Out in Tenth Consecutive Appearance on QVC Japan - Associated Press

Sarah Ferguson is telling all on how shes fighting the signs of aging.

Ive had a lot of help to look like this at 60! the ex-wife of Prince Andrew told UKs Daily Mail newspaper on Thursday. Ferguson, nicknamedFergie, revealed shes a fan of non-invasive laser facelifts to keep her features youthful.

Ive started the laser treatment, but its not finished yet, said the proud mom of Princess Eugenie and Princess Beatrice. The collagen needs to rebuild. I hope it will all be done by my birthday.

PRINCESS MADELEINE, PRINCE CARL PHILIP OF SWEDENS CHILDREN LOSE THEIR ROYAL TITLES

The Duchess of York said she used the same treatmentlast year to prepare forPrincess Eugenies royal wedding. People magazine reported the laser lift is meant to work as a natural facelift, stimulating collagen and refinishing skin texture.

Sarah Ferguson, Duchess of York, and Princess Beatrice of York arrive for the royal wedding of Princess Eugenie and Jack Brooksbank at St George's Chapel in Windsor Castle, Windsor, Britain October 12, 2018. (Reuters)

I dont like the frozen look, said Ferguson, who turns the big 6-0 on Oct. 15. Im so animated and I like to be myself. I dont like the thoughts of needles and am very glad if I look well and happy Im really happy to be open about what Ive had done.

ELIZABETH HURLEY MET MEGHAN MARKLE BEFORE PRINCE HARRY DID: 'SHE WAS FANTASTIC'

Ferguson admitted that in the past, she has tried Botox. But these days, Ferguson insisted she relies on more minimally invasive treatments. Shes a fan of mesotherapy, which uses injections of vitamins, minerals and amino acids to boost collagen production. Ferguson said the treatment was the right choice for her after years of sun damage.

I need to repair the damage that was done on the beach when I was a child, she said. Its why I had the mesotherapy, the vitamin cocktail to hydrate and boost the skin.

After that therapy session in 2013, Ferguson said she had a facial thread lift, which involves inserting amesh of medically advanced threads under the skin, lifting the face and smoothing away fine lines.

KATE MIDDLETON'S BROTHER JAMES ANNOUNCES ENGAGEMENT TO FRENCH GIRLFRIEND ALIZEE THEVENET

Sarah Ferguson arrives for the wedding ceremony of Prince Harry and Meghan Markle at St. George's Chapel in Windsor Castle in Windsor, near London, England, Saturday, May 19, 2018. (AP)

ELTON JOHN WRITES QUEEN ELIZABETH SLAPPED HER NEPHEW ACROSS THE FACE IN FRONT OF HIM IN NEW BOOK

Its like garden trellising for sweat peas, said Ferguson. You insert the threads under the skin with a fine needle and they hold everything up. They also encourage collagen production. It takes a couple of months, then the sweat peas blood.

Before I had it done I thought, Oh, this is going to be so painful, but it wasnt bad, Ferguson continued. My skin responded well. I think if you look at photos of me after I had it done, I look much better.

CLICK HERE TO GET THE FOX NEWS APP

And her face wasnt the only thing Ferguson focused on.

According to the outlet, Ferguson traveled to the Bahamas earlier this year to have regenerative stem cell therapy on her feet.

PRINCESS BEATRICE ENGAGED TO EDOARDO MAPELLI MOZZI

Sarah Ferguson is getting candid about how she's fighting the signs of aging. (Reuters)

PRINCESS CHARLOTTE 'LOVES' UNICORNS, DAD PRINCE WILLIAM SAYS

I think my toes were ruined by all the riding I did when I was young, she explained, pointing to her big toe. They shaved the bone here and implanted stem cells, 20 million of them taken from my midriff, into my feet to make new cartilage. It takes about six months to heal but now I can walk in heels!

Visit link:
Sarah Ferguson gets candid on using Botox, laser facelifts and stem cell therapy for her feet - Fox News

Posted: Oct 8, 2019 / 09:45 AM GMT-0600 / Updated: Oct 10, 2019 / 01:15 PM GMT-0600

Stem cell therapy is one of the most successful procedures ever for solving joint pain. Your own bodys cells are injected back into the area where healing is needed: back, neck, hip, shoulder, etc. The new cells signal to body the need for regeneration, which starts to take place.

The treatment is a one-and-done injection, no surgery. Regenerative Medicine of Utah successfully treats many with stem cell therapy. One patient, John Dunn, was scheduled for knee replacement because of bone on bone pain. Before surgery he received an injection. Three months later and regenerated tissue was found in his knee joint. Six months later his knee was even better than that.

In just four weeks John was out of pain, but the body wasnt done healing. The cells continue signaling to the body the need for healing. Its usual to allow 12 months for the regeneration process to complete and reach its limit.

Making sure youre a candidateis important. Not everyone needs it. Many patients that end up being a candidateinitially thought they werent eligible. To know if youre a candidate schedulea consultation.

Right now, at Regenerative Medicine ofUtah an evaluation is $49 for the first 25 callers to (800)453-0286.

This article contains sponsored content.

See the original post here:
How the bodys cells can prevent the need for surgery - ABC 4

The Duchess of York, affectionately known as Fergie by the British public, decided to have pioneering regenerative stem cell therapy to be able to wear heels again. Fergie had to give up on her stilettos for a long time due to the excruciating pain she felt every time she tried to walk in them. And if she forced herself to wear high heels to mark important occasions she had to endure pain throughout the whole day.

Her feet caused Fergie trouble even during Princess Eugenies wedding last October.

Speaking to the Daily Mail, the Duchess of York said her feet were in such pain she felt relieved to be able to sit down in the pew and rest them for a while before Eugenie entered St Georges Chapel.

The source of the pain seemed to be her big toe, and now, thanks to regenerative stem cell therapy the Duchess is no longer in pain every time she opts to wear shows other than flats.

Fergie headed to the Bahamas to undergo stem cell therapy - an alternative to surgery which is yet to be proven fully safe and effective on humans and is therefore not widely available in the UK.

Speaking about her trip, she said: I went to the Bahamas in March to have the treatment.

I think my toes were ruined by all the riding I did when I was young.

They shaved the bone here and implanted stem cells 20 million of them taken from my midriff into my feet to make new cartilage.

It takes about six months to heal but now I can walk in heels!

READ MORE:The touching reason Beatrice will have British wedding

Fergie underwent a series of treatments during the years, including vitamin injections, organic fillers and botox - which she had a long time ago, when there was nothing else available.

Ahead of Eugenies wedding, Fergie underwent laser treatment to look her best.

Fergie attributed her glowing skin on October 12, the day of Princess Eugenies wedding, to her happiness.

But she also revealed she did seek the help of a professional to improve her natural beauty.

She said: The happiness was shining out of me because my daughter was getting married.

DON'T MISS

I was so glad. I love Jack. When Im passionate about anything, my eyes shine.

Above all, it was being joyful for Eugenie that made me look good.

But Id had some laser treatment on my face which helped, too.

Despite having used several techniques to stave off ageing, Fergie said there is one she is no longer going to have - Botox.

She said: I had Botox a long time ago when there was nothing else available.

I really dont like the frozen look.

Im so animated and I like to be myself.

I dont like the thought of needles and am very glad if I look well and happy.

Fergie also said she has stopped sunbathing after suffering two losses in her life which helped her realise she must take care of her skin just as well as any other organs.

Here is the original post:
Sarah Ferguson was in pain during Eugenies wedding - and needed treatment to recover - Express

The nation's leading regenerative training company, R3 Stem Cell, today announced the addition of world renowned Exosomes expert Dr. Ian White as a speaker at its training courses. He will be speaking at the October 18, 2019 course on Exosomes and there are still a few spots remaining!

LAS VEGAS, Oct. 10, 2019 /PRNewswire-PRWeb/ -- R3 Stem Cell announces it has added an exosome presentation to its upcoming regenerative training courses. The next course is October 18-19th, 2019 in Las Vegas with spots still open.

The speaker, Dr. Ian White PhD, is a world renowned expert on exosomes. He completed training at several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the Chief Scientific Officer at IMAC Regeneration Centers along with being President of Biofirma, which is a regenerative tissue manufacturing company.

Dr. White regular speaks worldwide on the topic of exosomes, stem cells and how they participate clinically to help optimize regenerative therapy outcomes. Exosome stem cell therapy is an amazing therapeutic option for patients, however, most providers do not understand the biologics and how to implement them properly.

According to R3 CEO David Greene, MD, MBA, "Obtaining knowledge on exosomes is important now, as patients are asking about them! Providers need to understand when to use them, how they work, and should have hands on experience with them. Our training course provides all of that experience."

R3 Stem Cell is the nation's leader in regenerative training, and provides a comprehensive education and hands on experience for providers to become their local leader. Along with offering the first rate exosome presentation, R3 will also have exosomes products on hand for attendees to try in a hands on setting.

Limited spots are still available for the upcoming October 18-19, 2019 training in Las Vegas. R3 is still offering $1000 off for the training, visit https://stemcelltrainingcourse.org/registration/ to sign up or call (844) GET-STEM.

See the original post:
R3 Stem Cell Announces Addition of World Renowned Exosome Expert Dr. Ian White to Training Course - Yahoo Finance

A research report on Stem Cell Therapy for Multiple Sclerosis Market 2019 Industry Research Report is being published by researchunt.com. This is a key document as far as the clients and industries are concerned to not only understand the competitive market status that exists currently but also what future holds for it in the upcoming period, i.e., between 2018 and 2025. It has taken the previous market status of 2013 2018 to project the future status. The report has categorized in terms of region, type, key industries, and application.

A sample of report copy could be downloaded by visiting the site:marketreports.co/global-stem-cell-therapy-for-multiple-sclerosis-market-size-status-and-forecast-2019-2025/172555/#Free-Sample-Report

Global Stem Cell Therapy for Multiple Sclerosis revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023.

Major Geographical Regions

The study report on Global Stem Cell Therapy for Multiple SclerosisMarket 2018 would cover every big geographical, as well as, sub-regions throughout the world. The report has focused on market size, value, product sales and opportunities for growth in these regions. The market study has analyzed the competitive trend apart from offering valuable insights to clients and industries. These data will undoubtedly help them to plan their strategy so that they could not only expand but also penetrate into a market.

The researchers have analyzed the competitive advantages of those involved in the industries or in the Stem Cell Therapy for Multiple Sclerosisindustry. While historical years were taken as 2013 2017, the base year for the study was 2017. Similarly, the report has given its projection for the year 2018 apart from the outlook for years 2018 2025.

Key Players and Type

Like any other research material, the report has covered key geographical regions such as Europe, Japan, United States, India, Southeast Asia and Europe. Researchers have given their opinion or insights of value, product sales, and industry share besides availability opportunities to expand in those regions. As far as the sub-regions, North America, Canada, Medico, Australia, Asia-Pacific, India, South Korea, China, Singapore, Indonesia, Japan, Rest of Asia-Pacific, Germany, United Kingdom, France, Spain, Italy, Rest of Europe, Russia, Central & South America, Middle East & Africa are included.

Major players in the report included are :

Types covered in theStem Cell Therapy for Multiple Sclerosisindustryare :

Applications covered in the report are :

Report Aims

The objective of the researchers is to find out sales, value, and status of the Stem Cell Therapy for Multiple Sclerosisindustry at the international levels. While the status covers the years of 2013 17, the forecast is for the period 2018 25 that will enable market players to not only plan but also execute strategies based on the market needs.

Read Detailed Index of full Research Study at @marketreports.co/global-stem-cell-therapy-for-multiple-sclerosis-market-size-status-and-forecast-2019-2025/172555/

The study wanted to focus on key manufacturers, competitive landscape, and SWOT analysis for Stem Cell Therapy for Multiple Sclerosisindustry. Apart from looking into the geographical regions, the report concentrated on key trends and segments that are either driving or preventing the growth of the industry. Researchers have also focused on individual growth trend besides their contribution to the overall market.

There are 15 Chapters to display the GlobalStem Cell Therapy for Multiple Sclerosismarket.

Sections 1. Industry Synopsis of Global Stem Cell Therapy for Multiple Sclerosis Market.

Sections 2. Stem Cell Therapy for Multiple Sclerosis Market Organization Producers analysis and Profiles.

Sections 3. Stem Cell Therapy for Multiple Sclerosis Market Size by Type and Application.

Sections 4. Global Stem Cell Therapy for Multiple Sclerosis Market 2018 Analysis by key traders.

Sections 5. Europe Stem Cell Therapy for Multiple Sclerosis Industry Report Development Status and Outlook.

Sections 6. Japan Stem Cell Therapy for Multiple Sclerosis Industry Report Development Status and Outlook.

Sections 7. Development Status and improvements of Stem Cell Therapy for Multiple Sclerosis Market in the United States.

Sections 8. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Improvement Status and Outlook.

Sections 9. China Stem Cell Therapy for Multiple Sclerosis Market Report Development Status and Outlook.

Sections 10. India Stem Cell Therapy for Multiple Sclerosis Market Development Status and Outlook.

Sections 11. Stem Cell Therapy for Multiple Sclerosis Market Figure by Aoplications, areas, and Sorts (2018-2023)

Sections 12. Stem Cell Therapy for Multiple Sclerosis Market Factors Analysis.

Sections 13. Stem Cell Therapy for Multiple Sclerosis Market Dynamics.

Sections 14. Research Findings and Conclusions of Stem Cell Therapy for Multiple Sclerosis Market.

Sections 15. Appendix.

Browse Detailed TOC, Tables, Figures, Charts And Companies Mentioned In Stem Cell Therapy for Multiple Sclerosis Market Research Report At@marketreports.co/global-stem-cell-therapy-for-multiple-sclerosis-market-size-status-and-forecast-2019-2025/172555/#Buying-Enquiry

Read more:
Stem Cell Therapy for Multiple Sclerosis Market 2025: Topmost manufacturers With Size, Regions, Types, Major Drivers, Profits - TheFinanceTime

Regenerative medicine is a segment of translational research in molecular biology and tissue engineering. It involves the process of regeneration of human cells, tissues, or organs to re-establish their normal functions through stimulation of bodys repair system. They are widely used in the treatment of many degenerative disorders occurring in the areas of dermatology, orthopedic, cardiovascular and neurodegenerative diseases. Stem cell therapy is the available tool in the field of translational regenerative medicine. It has gained importance in the past few years as it is a bio-based alternative to synthetic options. Stem cells have high power of regeneration. Hence, these enable production of other cells in the body. This has increased demand for stem cell therapy in the treatment of degenerative diseases. Currently, stem cell therapy has applications in the treatment of diseases such as autism, cancer, retinal diseases, heart failure, diabetes, rheumatoid arthritis, Alzheimers. Extensive research is being carried out on stem cell therapy. The Centre for Commercialization of Regenerative Medicine (CCRM) has reported around 1900 active clinical trials undergoing currently. It also reported 574 active industry-sponsored cell therapy clinical studies, 50 of these are in phase 3 development. Hence, stem cell therapy is projected to contribute to the growth of the translational regenerative medicine market. However, ethical issues in the use of embryonic stem cells is likely to restrain the market.

Rising prevalence of degenerative diseases, aging population, rapid growth of emerging countries, and technical advancements in developed countries are the major factors fueling the growth of the translational regenerative medicine market.

Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/translational-regenerative-medicine-market.html

The global translational regenerative medicine market has been segmented based on product type, therapy, application, and region. In terms of product type, the market has been categorized into cellular and acellular. The cellular segment dominated the global market in 2016. Based on therapy, the global translational regenerative market has been segmented into cell therapy, gene therapy, immunotherapy, and tissue engineering. Immunotherapy is projected to be the fastest growing segment during the forecast period. In terms of application, the market has been segmented into orthopedic & musculoskeletal, cardiology, diabetes, central nervous system diseases, dermatology, and others. Cardiology and orthopedic & musculoskeletal are anticipated to be the fastest growing segments of the global translational regenerative medicine market.In terms of region, the global translational regenerative medicine market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the global regenerative medicine market owing to a large number of leading companies and expansion of research and development activities in the U.S. Increased medical reimbursement and advanced health care also drive the market in the region. Orthopedic is the leading application segment contributing to the growth of the market in the region. Asia Pacific is forecasted the huge growth because of large consumer pool, rising income, and health care expenditure. However, the market in Asia Pacific could face challenges such as high cost of bio-based medicines and stringent regulatory policies.

The global translational regenerative medicine market is dominated by key players such as CONMED Corporation, Arthrex, Inc., Organogenesis, Inc., Nuvasive, Inc., Osiris Therapeutics, Inc., Celgene Corporation, Brainstorm Cell Therapeutics Inc. and Medtronic.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request For Custom Research At https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=30440&source=atm

The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis

The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market

Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request for TOC of This Report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=30440&source=atm

Read the original here:
Translational Regenerative Medicine Market Estimated to Expand at a Robust CAGR over 2017 2025 - Online News Guru

With office locations in Los Angeles, Encino, Rancho Cucamonga, Lancaster, Beverly Hills, Studio City, and San Francisco, Advanced Stem Cell Institute prides itself on helping people to achieve optimal health with the use of stem cell injections throughout California.

At our stem cell therapy center, we can help guide you through the stem cell therapy process. To determine if youre a good candidate, we must review your medical history. Once we review this and discuss with you your current ailments and/or medical conditions, we can make professional decisions on whether stem cell therapy is right for you. If approved, we will develop a custom treatment plan that is mapped out for you, so you can understand the process ahead.

Learn More About Stem Cell Injections

Stem cell injections have been proven to help a variety of types of patients. Advanced Stem Cell Institute is your best option to improve the quality of your life by providing the best stem cell operations through the most innovative non-surgical methods. Many painful conditions are treated including degenerative arthritis, sports injuries, migraines, spinal stenosis, tendonitis, ligament injuries, whiplash, erectile dysfunction, and failed back surgery to name a few!

The state-of-the-art stem cell therapy options at Advanced Stem Cell Institute are incredibly successful. We have over seven years of experience providing the best stem cell treatment and natural pain management and are recognized members of the American Academy of Regenerative Medicine, American Academy of Orthopedic Medicine, and American Academy of Pain Management.

Ultimately, stem cell injections are a great alternative to surgery, and we have many financing options so you can get the treatment you need no matter your financial situation. If youre looking for the best alternative medicine and joint pain relief around, look no further than Advanced Stem Cell Institute. Advanced Stem Cell Institute has locations in Los Angeles, Encino, Rancho Cucamonga, Lancaster, Beverly Hills, Studio City, and San Francisco. Contact us today, and we will get you set up with a consultation!

About Cord Stem Cell Therapy

Cord stem cell therapy is among some of the most powerful. Cord blood from the umbilical cord and placenta has rich cells that can repair and restore different parts of the body easily. These oxygen-rich cells from the placenta go to the baby, allowing it to have nutrient dense blood which helps it to grow. The umbilical cord itself has two types of stem cells cord tissue stem cells and cord blood stem cells. Cord stem cell therapy has been proven to help treat countless diseases.

Read the original:
ADSC My WordPress Blog

Stem Cell Therapy is a non-invasive therapy, which is in oral capsules form that digests through the small intestine. Stem Cell Therapy starts with a selection of organ general cells from the Sheep. Able sheep placenta capsules are protein and hormone free. There is no animal sacrifice or blood utilized for this purpose. Able sheep placenta oral stem cells offer the best quality program for cellular nourishment. Our oral stem cells can help with general nutritional support needs without any side effect. From a nutritional standpoint, Able sheep placenta oral stem cells can show an improvement within the first month. Able oral stem cells in capsule form are compatible with the human body and are not recognized as foreign. They are digested through the small intestines and in turn distributed to where is needed for nutritional support. The organ itself can retain its vigor and vitality from a nutritional standpoint.

Able oral stem cell therapy in capsule form can be taken for nutritional support and to help with health ailments naturally. Able oral stem cells are free of hormones and proteins and its main ingredients of high-quality sheep placenta and Salmon can help foremost with the immune system and neurologically. Other benefits are a digestive system, mental alertness, sleep pattern, etc. Able oral stem cells use a micro extract technology and offer the highest quality ingredients for maximum results. The cellular nourishment is both internal and external in giving you vitality and great looking skin.

Our live cell therapy, oral stem cells can help reduce joint pain, knee pain, hips, back, and inflammation. It can also help with mental alertness, physical movement, digestive system, sleep pattern, high blood pressure and the immune system in general.The Able oral stem cells program is recommended for up to six to eight months and the dosage can be between one to three capsules per day.(Direct cure claims cannot be made).

View post:
Stem Cell Therapy to effectively treat chronic diseases

April 27, 2018

Mayo Clinic is enrolling patients in a phase 1 clinical trial of adipose stem cell treatment for spinal cord injury caused by trauma. The researchers already have approval from the Food and Drug Administration for subsequent phase 2A and 2B randomized control crossover trials.

Participants in the phase 1 clinical trial must have experienced a trauma-related spinal cord injury from two weeks to one year prior to enrollment. They will receive intrathecal injections of adipose-derived mesenchymal stem cells. No surgery or implantable medical device is required.

"That is the most encouraging part of this study," says Mohamad Bydon, M.D., a consultant in Neurosurgery specializing in spinal surgery at Mayo Clinic in Rochester, Minnesota, and the study's director. "Intrathecal injection is a well-tolerated and common procedure. Stem cells can be delivered with an implantable device, but that would require surgery for implantation and additional surgeries to maintain the device. If intrathecal treatment is successful, it could impact patients' lives without having them undergo additional surgery or maintain permanently implantable devices for the rest of their lives."

To qualify for the trial, patients must have a spinal cord injury of grade A or B on the American Spinal Injury Association (ASIA) Impairment Scale. After evaluation at Mayo Clinic, eligible patients who enroll will have adipose tissue extracted from their abdomens or thighs. The tissue will be processed in the Human Cellular Therapies Laboratories, which are co-directed by Allan B. Dietz, Ph.D., to isolate and expand stem cells.

Four to six weeks after the tissue extraction, patients will return to Mayo Clinic for intrathecal injection of the stem cells. The trial participants will then be evaluated periodically for 96 weeks.

Mayo Clinic has already demonstrated the safety of intrathecal autologous adipose-derived stem cells for neurodegenerative disease. In a previous phase 1 clinical trial, with results published in the Nov. 22, 2016, issue of Neurology, Mayo Clinic researchers found that therapy was safe for people with amyotrophic lateral sclerosis (ALS). The therapy, developed in the Regenerative Neurobiology Laboratory under the direction of Anthony J. Windebank, M.D., is moving into phase 2 clinical trials.

Dr. Windebank is also involved in the new clinical trial for people with traumatic spinal cord injuries. "We have demonstrated that stem cell therapy is safe in people with ALS. That allows us to study this novel therapy in a different population of patients," he says. "Spinal cord injury is devastating, and it generally affects people in their 20s or 30s. We hope eventually that this novel therapy will reduce inflammation and also promote some regeneration of nerve fibers in the spinal cord to improve function."

Mayo Clinic's extensive experience with stem cell research provides important guidance for the new trial. "We know from prior studies that stem cell treatment can be effective in aiding with regeneration after spinal cord injury, but many questions remain unanswered," Dr. Bydon says. "Timing of treatment, frequency of treatment, mode of delivery, and number and type of stem cells are all open questions. Our hope is that this study can help answer some of these questions."

In addition to experience, Mayo Clinic brings to this clinical trial the strength of its multidisciplinary focus. The principal investigator, Wenchun Qu, M.D., M.S., Ph.D., is a consultant in Physical Medicine and Rehabilitation at Mayo Clinic's Minnesota campus, as is another of the trial's investigators, Ronald K. Reeves, M.D. Dr. Dietz, the study's sponsor, is a transfusion medicine specialist. Also involved is Nicolas N. Madigan, M.B., B.Ch., BAO, Ph.D., a consultant in Neurology at Mayo Clinic's Minnesota campus.

The study team is in discussions with U.S. military medical centers to enroll patients, and discussing additional collaboration with international sites, potentially in Israel or Europe, for future phases of the study.

"At Mayo Clinic, we have a high-volume, patient-centered multidisciplinary practice," Dr. Bydon says. "That allows us to do the most rigorous scientific trial that is in the best interests of our patients."

Mayo Clinic. Adipose Stem Cells for Traumatic Spinal Cord Injury (CELLTOP). ClinicalTrials.gov.

Staff NP, et al. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS. Neurology. 2016;87:2230.

Read more:
Clinical trial of stem cell therapy for traumatic spinal cord ...

In accordance with the FTC guidelines concerning use of endorsements and testimonials in advertising, please be aware of the following:Federal regulations require us to advise you that all review, testimonials, and/or endorsements of any kind reflect on the personal experience of those individuals who have expressed their own personal opinions and that those opinions and experiences may not be representative of what every consumer may personally experience with the endorsement.All reviews and testimonials are the sole opinions, findings, and/or experiences of the people sharing their stories. They are not compensated in any way.These statements have not been evaluated by the US Food and Drug Administration (FDA). We are required to inform you that there is no intention, implied or otherwise that these statements be used in the cure, diagnosis, mitigation, treatment, and/or prevention of disease.These testimonies do not imply that similar results would or could happen to you.These testimonials are not intended to diagnose, for specific illness or conditions, nor as treatment to eliminate diseases or other medical conditions or complications.We make no medical claim as to the benefits of anything to improve medical conditions.

Stem cells are powerful building blocks. They have the ability to help your body from the inside out without medications or surgery. At Achieve Vitality, we focus on helping you. We believe that the power that created you can heal you.

See the original post here:
Stem Cell Therapy | Achieve Vitality Regenerative Wellness

Broadly speaking, there are two basic kinds of stem cells: embryonic stem cells and adult stem cells. As the name implies, embryonic stem cells come from embryos. These kinds of cells are known as pluri-potential, meaning that they can become anything required to create a human body. Embryonic stem cells are taken from unwanted embryos, and as such, are highly controversial. Embryonic stem cell use is highly regulated and has also been associated with certain kinds of tumor formation.

Adult stem cells, on the other hand, come from adults. Adult stem cells are harder to isolate, but still retain many (but not all) of their undifferentiated properties, allowing them to become nerve, skin, bone, cartilage and other tissues as needed, depending on the specific type of tissue they are recovered from. Bone marrow adult stem cells (mesenchymal stem cells), for instance, come from the mesodermal sections of the human body and can form into cartilage and bone.

Evidence suggests that they are also capable of differentiating into other tissues like connective tissues (ligaments, muscle, tendons), blood vessels, fatty tissues, nerve and blood vessels. Bone marrow stem cells are not as prevalent in the body and usually need to be cultured (encouraged to multiply in the lab) so that there are enough to work with.

Fortunately, human fat cells also have mesenchymal stem cells (MSCs) which can be more easily harvested and separated from fat cells for use. Because the ratio of mesenchymal stem cells (MSCs) is over a thousand times greater in fat cells than bone marrow, these usually do not need to be cultured and can be obtained from fatty deposits in the patients body.

Original post:
Stem Cell Therapy FAQS | National Stem Cell Centers

What are Stem Cells?

Stem cells are undifferentiated cells that can self-replicate then develop into many different types of cells and tissue. Adult stem cells continuously divide and grow into new cells to repair and replace tissues that are old, damaged, or diseased.

There are different types of adult stem cells. Some produce one specific tissue, while others can replicate several types of cells. Stem cell therapy utilizes adult stem cells that can repair multiple tissues.

When a concentrated amount of stem cells are injected directly into damaged tissues, the stem cells regenerate and repair the damage by producing the new cells.

The stem cells used for your injection come from your own body. One type, mesenchymal cells, are particularly effective for orthopedic conditions and sports injuries because they regenerate cells common in musculoskeletal tissues, including bones, tendons, cartilage, and ligaments.

Your doctor at Bluetail Medical Group extracts adult mesenchymal stem cells from bone marrow in your hip. After processing and concentrating the stem cells, your doctor injects them into the damaged tissues using ultrasound-guided imaging.

Stem cell therapy has successfully treated many orthopedic conditions, including tendon, ligament, and muscle injuries, joint damage, and nerve pain.

These are just a few examples of health problems treated with stem cell therapy at Bluetail Medical Group:

As experts in regenerative medicine, the team at Bluetail Medical Group are available to talk with you about whether stem cell therapy may help your condition.

Platelet-rich plasma (PRP) uses growth factors naturally found in your blood platelets to promote healing, trigger new tissue growth, and enhance the activity of stem cells. When your injury or disease is extensive, or you have degenerative joint disease, a tendon tear, or osteoarthritis, your doctor may add PRP to your stem cell injection.

Like stem cell therapy, PRP is made on-site from your blood. Your doctor draws a blood sample and processes it in a centrifuge that separates platelets from other blood components. This concentrated sample of platelets can be combined with your stem cell injection for accelerated healing.

If youre not getting the results you want from your current treatment, it may be time to consider stem cell therapy. Call Bluetail Medical Group or book an appointment online.

More:
Stem Cell Therapy Specialist - Chesterfield, MO & Columbia ...

Stem Cell Therapy for Neuropathy

Neuropathy is a condition characterized by pain of the limbs, such as arms, hands, feet, and/or legs. Neuropathic (nerve-related) pain is initiated/caused by dysfunction of the nervous system. Most common symptoms of neuropathy include extreme sensitivity and dramatic response to pain. A new, innovative treatment for neuropathy is stem cell therapy.

Neuropathy and nerve-related pain reduces human well-being and is difficult to manage. Around 100 million people in the United States report chronic pain. The use of stem cells has proven to be effective at lessening the pain associated with diabetic neuropathy and peripheral nerve pain. Clinical evidence shows that stem cell therapy provides the best results and could decrease the use of pain medication.

How do stem cells work to treat neuropathic pain?

Stem cell therapy shows great promise for regenerative medicine in the treatment of peripheral neuropathy. Stem cells help slow the disease progression. In rat subjects, bone marrow-derived stem cells have shown promise in treating neurodegenerative disease, which proves neuroprotective when given intravenously (IV). Stem cell implantation has also been shown to work in the repair of axon regeneration and synapse reformation, which are structures of the nerve cell.

Do stem cells help treat pain?

Stem cell differentiation is thought to be the key to pain control. Serotonergic neural precursor cell grafts reduce hyperexcitability caused by pain. Neuropathic pain causes a decrease in the activity and number of neurons called GABA. The stem cells express anti-nociceptive molecules and/or trophic factors that have been found to relieve neuropathic pain. In addition, stem cells are used as pumps to deliver anti-nociceptive molecules close to the pain processing sites of nerve damage.

Which cells are most used in the treatment of peripheral neuropathy?

Mesenchymal stem cells (MSCs) are showing the most promise in pain care research. These cells are a group of progenitor cells of mesodermal origin, which are found in adult bone marrow. These cells give rise to skeletal muscle cells, fat, blood, and connective tissues. MSCs also have a stable phenotype and are easily transported from the laboratory to physician office. These cells also migrate to the site of nerve damage and have good immunosuppressive properties.

Do clinical studies support the use of stem cells for peripheral neuropathy?

In a recent study in The Journal of Pain Research, researchers used stem cells for neuropathy relief successfully. They found that the treatment produced 60% relief at a six month time point. Because neuropathic pain impacts quality of life, it can be quite costly to the healthcare system. Researchers are continuing to study this problem.

Tulane University Center for Stem Cell Research conducted many studies using MSCs. They found these cells were effective and safe for treating inflammatory disease, such as peripheral neuropathy. The cells were found to optimize their anti-inflammatory effects. In mice subjects, researchers noted a 40% improvement rate.

What results can I expect with stem cell therapy for neuropathy?

Response to stem cell therapy usually starts within a few weeks to months. Patients often report effectiveness within 3-6 months. Patients with peripheral neuropathy respond over 60% of the time, according to studies. A second treatment may become necessary depending on the individual and therapy also involves several additional modalities such as light therapy and nutritional optimization.

Resources

Siniscalco D, Rossi F, & Maione S (2007). tem cell therapy for neuropathic pain treatment. J Stem Cells Regen Md, 3(1), 2-11.

A preliminary report on stem cell therapy for neuropathic pain in humans, Vickers et al,J Pain Res. 2014; 7: 255263.

More here:
Stem Cell Therapy For Neuropathy | Stem Cell Therapy

Hi @jlsoerensOne of the focus areas on Mayo Clinic's Regenerative Medicine Program is in neuroregeneration. You can read more here: https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/focus-areas/neuroregeneration Scroll down the page and you can read clinical research being done specifically for peripheral nerve regeneration and repair.

Unfortunately, because of the complexity of the brain and spinal cord, little spontaneous regeneration, repair or healing occurs. Therefore, brain damage, paralysis from spinal cord injury and peripheral nerve damage are often permanent and incapacitating.

To learn more, you may wish to contact Mayo Clinics Regenerative Medicine free Consult Service. If you call them, you will talk to a live person who will provide more information, research, and advice on seeking stem cell therapy from reputable providers, even if that provider is not Mayo Clinic. Their primary goal is to educate and help you find effective treatment. Furthermore, you can add your name to a database to be notified when additional studies and information become available. Heres more information about the stem cell Consult Service http://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-services/regenerative-medicine-consult-service. Or simply call 1-844-276-2003 to speak with one of our experts.

I also feel it important to add it is so important to do your homework and due diligence when researching new treatment options. Stem cells offer a lot of hope. But where these is hope, there is hype and charlatans. FDA acts to remove unproven, potentially harmful treatment used in stem cell centers targeting vulnerable patients https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm573427.htm

You can read more about stem cells on the FDAs website here: https://www.fda.gov/AboutFDA/Transparency/Basics/ucm194655.htm

Read more:
Stem Cell Therapy for Neuropathy | Mayo Clinic Connect

The topic may be fraught with questions and misconceptions, but its important to discuss the pros and cons ofstem cell therapy. Why are some people against stem cell research? What are the possible benefits of stem cell therapy in the field of regenerative treatment? When balancing an ethical debate, its important to weigh facts.

There have been some controversies surrounding the procedures involved in stem cell therapy. However, most of the criticism surrounding this research is related to human embryonic stem cells: the ethical questionability of acquisition, and the surrounding issues about donation consent.

Embryonic stem cells (ES) have important qualities for a successful stem cell therapy: pluripotency, unlimited capability for self-renewal, and a huge potential when it comes to the field of transplantation and tissue engineering. However, embryonic cells are acquired from the inner mass of cells of a blastocyst: an early-stage, pre-implantation human embryo. The controversy then is the isolation of the ES and how it results in the destruction of human embryos. Some people see the destruction of the blastocysts as equal to the destruction of an unborn human life, while others argue that the embryo is not exactly a human being yet.

Stem cell research is a relatively new field: the first occurrence of the term stem cell in scientific literature was in 1868, when Ernst Haeckel, a German biologist used it to describe the fertilized egg that eventually becomes an organism. In 2001, President George W. Bush signed an order authorizing the use of federal funding for a limited number of cell lines. Additionally, as with any new technology or research field, the long-term effects of stem cell therapy has not yet been examined.

Multipotency is one of the most important characteristics of stem cells to be effective in treatment. On the other hand, adult stem cells, which are non-embryonic stem cells, carry the risk of unipotency. Therefore the adult cells could be pre-specialized, and create only particular progeny. Neural stem cells run the risk of producing only brain cells, greatly limiting the regenerative potential for patients with Alzheimers and Parkinsons disease.

In spite of the cons, stem cell research is a more than a promising field of medical research. Its being eyed as a possible solution for diseases that are currently incurable. This is due to the fact that stem cell transplants and research explores one foundational human interest: the human bodys amazing capability to repair and heal itself.

Stem cell research is a powerhouse in the fields of therapeutic cloning, regenerative medicine, drug development/testing, and organ development and transplant. It will also shed light on previously unexamined aspects of early human development. All of which can potentially help in the prevention of birth defects, infertility, and miscarriages. Stem cell research will bring forth an era of enlightenment in terms of human growth.

Stem cell research will usher in a brand new understanding of human physiological functions, resulting in a surge of medical advancements. It could also introduce prevention and/or cure for degenerative diseases. Some of the diseases which may be reversible through advancements in the field of stem cell research include:

Adult stem cells hold the key to the bodys self-repair mechanism. Adult cells are mesenchymal stem cells and pluripotent stem cells which have advanced the use of stem cell therapy to reverse aging. Additionally, through the repair or replacement of worn organs, the length and quality of human life have the chance to improve.

Here are some of the advancements by scientists in the field of stem cell research, delivered by Wall Street Journal!

Stem cell research has been through a number of debates and assessments based on the pros and cons of stem cell therapy. However, this hasnt stopped scientists to research its potential. Whatever your stance may be when it comes to stem cell research, its important to consider the possibilities this research holds. Find the nearest research center or laboratory and ask around for more information!

Do you have questions about stem cell research? Whats your stance on embryonic stem cell research? Share your thoughts in the comments box below!

Up Next:Umbilical Cord Blood Stem Cells Pros and Cons

Editors Note This post was originally published on November 2, 2017 and has been updated for quality and relevancy.

Pros And Cons of Stem Cell Therapy

See the original post:
Pros And Cons of Stem Cell Therapy | Stem Cell Researchers

Stem Cell Therapy in Florida, Stem Cell Treatment Florida | Stemedix

Trained medical staff experienced in your diagnosis and treatment.

Contact us today

Our success is dependent on your wellness. Begin your new journey today.

Sign up today

Leading the way with groundbreaking regenerative stem cell treatment.

Learn more

Groundbreaking advancements in Stem Cell treatment are giving patients the ability to fight back against diseases once thought untreatable. Your journey to wellness begins here with a knowledge and understanding of Adult Stem Cell therapy.

Learn more

What are Adult Stem Cells? How do adult stem cells work? What is Adult Stem Cell Transplantation? Visit our Frequently Asked Questions page for answers to many common questions regarding Stem Cell Treatment.

Learn more

Is Adult Stem Cell Therapy right for you? Contact Stemedix today and speak to a Care Coordinator that can help answer your questions and assist you through the initial discovery phase of Adult Stem Cell treatment. Se Habla Espaol!

Contact us

It was a very good experience. My husband just really liked the doctor alot.He thought he was just excellent.

Bonnie B. for husband William B. (COPD), Davenport, FL

I just want to say thanks to everyone who was involved, the nurses, the doctors It was an amazing treatment.

Levi L. for wife Denise L. (Nerve Damage), Orlando, FL

Bottom line, we are very well pleased. If someone were to ask me I would tell them, "go for it".

Joe R. for wife Aracelli R. (Alzheimer's), La Porte, TX

It is difficult to find any issue with the organization, the set up, or the procedure itself...very pleased.

Glenn M. (Parkinson's), Bellaire Bluffs, FL

Thank you so much for being so amazing to work with. I am already noticing some results from my first treatment and am looking forward to my next procedure!

Randina J. (Multiple Sclerosis), Charlotte, NC

"I was totally satisfied with the experience! After the procedure my tremors subsided and could stand much better."

Dominic G. (Multiple Sclerosis), Merritt Island, FL

"Everything was top notch! From the moment we arrived at the airport till the time we returned."

Mary M. (ALS), Houston, TX

"The staff was amazing and the whole experience was easy and stress free. This was a great decision."

Stevan K. (ALS), Allen, TX

"Overall the process/procedure was very pleasant. The hotel was great. The doctor's office was very professional and freindly. The doctor was great. The office staff was great."

Mary H. (Multiple Sclerosis), Leesburg, FL

More Stemedix reviews

Aging is a complex process that our bodies experience as we grow older. The process of aging involves every cell and organ to undergo a steady rate of deterioration.

Learn more

ALS is one of the muscle conditions in the muscular dystrophy spectrum.It stands for Amyotrophic Lateral Sclerosis, but it is more commonly known as Lou Gehrigs Disease.

Learn more

Alzheimers Disease (AD) is a form of dementia which causes memory loss and can inhibit intellectual abilities severely enough to interfere with a persons daily activities.

Learn more

CFS also known as chronic fatigue immune dysfunction syndrome (CFIDS) and myalgic encephalomyelitis (ME) is a complicated disorder that is not relieved by sleeping or resting and is progressive.

Learn more

One of the most common lung diseases COPD refers to a group of lung conditions that make it difficult tobreathe by blocking the airflow in and out of the lungs; emphysema, chronic bronchitis, and chronic asthma.

Learn more

Lupus is an autoimmune disease in which ones immune system becomes hyperactive and attacks healthy, normal living tissue. There are many kinds of lupus with varying symptoms.

Learn more

MS is a degenerative disease in which the central nervous system (CNS) is attacked by an abnormal immune response causing inflammation and exposure of nerve fibers.

Learn more

The chronic disease Osteoarthritis (OA) is characterized by the breakdown of cartilage. As the cartilage in jointsof the body deteriorate, bones begin to rub against one another.

Learn more

Parkinson's is known as a progressive disease in which brain cell damage worsens and/or spreads over periods of time. The rate of progression is unique to each patient with symptoms varying...

Learn more

Rheumatoid Arthritis (RA) is an inflammatory autoimmune disease of which an individuals musculoskeletal system is compromised by and abnormal immune response.

Learn more

Sports and Regenerative Medicine is a catch all term for a variety of different conditions. Sports medicine started with the treatment of the musculoskeletal injuries that occurred while engaging in athletics...

Learn more

For our International Customers - Please note, all shipments will need to be quoted. Please give us a call before placing order. Dismiss

Go here to read the rest:
Stem Cell Therapy in Florida, Stem Cell ... - Stemedix

Leading Stem Cell Therapy in Florida

The human body is built to heal itself. If youve experienced an injury or other chronic condition that has left you with pain, you have options. Stem cell therapy repairs damaged tissue in your body to restore your health. You can finally live a life free from pain!

While there are many sources of stem cells, Regenerative Health Centers of Florida uses cells harvested from umbilical cords. These cells are grown into specialized cells to help with muscle, ligaments, cartilage, nerves, and more. Specialized stem cells are injected into problem areas through a quick procedure. The stem cells then grow and repair within the affected area, delivering lasting results.

You dont have to live with chronic pain. Stem cells are a successful and safe way to treat a variety of conditions and injuries. Under the leadership of Dr. Michael Lampe and Dr. Jana Lampe, Regenerative Health Centers of Florida has helped people relieve their pain and heal injuries!

Using a quick and proven process, stem cell therapy delivers results that heal your body permanently. Contact the specialists at Regenerative Health Centers of Florida today to explore if this treatment is right for you.

Nobody should have to live their life with pain. If youre suffering from chronic pain or injuries,stem cell therapymight be the right treatment for you. We focus on the patient experience at every step of the way at Regenerative Centers of Florida. We know how frustrating it is to try treatment and medication with no success. You just want something that actually works for you.

We offer next generation healthcare. We offer long-term pain relief without relying on harsh surgery or a lifetime of medication. Regenerative therapy is natural, and it uses your bodys own healing powers to solve even complex pain problems.

Stem cell therapy is risk-free with no reported negative side effects. Not only is the treatment fast and painless, but youll be on your way to lasting relief in just a few weeks. The results of stem cell therapy last a lifetime since they heal your body from the inside out. That means no more complicated procedures, and no more living your life with pain. This is the treatment youve been waiting for! See our services below to explore the best option for you.

Stem Cell Therapy

Stem cells treat a number of injuries and conditions. Stem cells are unspecialized cells which divide to repair and replace damaged tissue, cartilage, ligaments, and even nerves. They grow into only what is needed, meaning your body can regrow healthy tissue naturally. Stem cell therapy is a quick procedure with practically zero recovery time!Click here to learn more about stem cell therapy.

The rest is here:
Stem Cell Therapy - Regenerative Health Centers of Florida